{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Agenus", "item": "https://www.patentleaderboard.com/2021/company/agenus"}, {"@type": "ListItem", "position": 4, "name": "Marc van Dijk", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ma_ln:vandijk-15"}]}

Home › 2021 › Agenus › Marc van Dijk

MD

Marc van Dijk — 6 Patents in 2021

AGAgenus: 6 patents #2 of 29Top 7%

LRLudwig Institute For Cancer Research: 3 patents #1 of 37Top 3%

MCMemorial Sloan Kettering Cancer Center: 3 patents #5 of 231Top 3%

Bosch en Duin, NL: #1 of 3 inventorsTop 35%

Overall (2021): #21,457 of 548,734Top 4%

6 Patents 2021

Issued Patents 2021

Showing 1–6 of 6 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11136404	Anti-OX40 antibodies	Ekaterina V. Breous-Nystrom, Volker Seibert, Gerd Ritter, David Schaer, Daniel Hirschhorn-Cymerman +5 more	2021-10-05	$20,506,000
11098117	Anti-CD137 antibodies and methods of use thereof	Yanping Xiao, Nicholas Stuart Wilson, Benjamin Maxime Morin, Mark A. Findeis, Cornelia Anne Mundt +4 more	2021-08-24	$23,776,000
11013802	Anti-CTLA-4 antibodies and methods of use thereof	Cornelia Anne Mundt, Gerd Ritter, David Schaer, Jedd D. Wolchok, Taha Merghoub +7 more	2021-05-25	$17,085,000
10912828	Anti-TIM-3 antibodies and methods of use thereof	Ekaterina V. Breous-Nystrom, Nicholas Stuart Wilson, Jeremy Dale Waight, Dennis John Underwood	2021-02-09	$9,174,000
10912831	Anti-CTLA-4 antibodies and methods of use thereof	Cornelia Anne Mundt, Gerd Ritter, David Schaer, Jedd D. Wolchok, Taha Merghoub +7 more	2021-02-09	$9,174,000
10882908	Anti-LAG-3 antibodies and methods of use thereof	Nicholas Stuart Wilson, David Adam Savitsky, Shawn Michael Jennings, Cornelia Anne Mundt	2021-01-05	$11,585,000